PIK3CA and cancer: According to cBioPortal analysis of published cancer genomics datasets such as The Cancer Genome Atlas4, breast cancer is frequently characterized by genetic alterations of PIK3CA (~35–45%, mostly activating mutations) and PTEN (~6–10%, mostly inactivating mutations or deletions).